Heterogeneity of the proliferative fraction and cyclin D1/CCND1 gene amplification in head and neck squamous cell carcinoma

Cytometry ◽  
1995 ◽  
Vol 21 (1) ◽  
pp. 47-51 ◽  
Author(s):  
Adel K. El-Naggar ◽  
Kim Steck ◽  
John G. Batsakis
2011 ◽  
Vol 145 (2_suppl) ◽  
pp. P62-P63
Author(s):  
J. K. J. Rasamny ◽  
Amir Allak ◽  
Henry Frierson ◽  
Maria Policarpio-Nicolas ◽  
Vickie Jo ◽  
...  

2020 ◽  
Vol 9 (10) ◽  
pp. 3214 ◽  
Author(s):  
Eric Remer ◽  
Mai Badarni ◽  
Elad Hikri ◽  
Avraham Dayan ◽  
Lirit Levi ◽  
...  

Activating alterations in PIK3CA, the gene coding for the catalytic subunit of phosphoinositide-3-kinase (PI3K), are prevalent in head and neck squamous cell carcinoma (HNSCC) and thought to be one of the main drivers of these tumors. However, early clinical trials on PI3K inhibitors (PI3Ki) have been disappointing due to the limited durability of the activity of these drugs. To investigate the resistance mechanisms to PI3Ki and attempt to overcome them, we conducted a molecular-based study using both HNSCC cell lines and patient-derived xenografts (PDXs). We sought to simulate and dissect the molecular pathways that come into play in PIK3CA-altered HNSCC treated with isoform-specific PI3Ki (BYL719, GDC0032). In vitro assays of cell viability and protein expression indicate that activation of the mTOR and cyclin D1 pathways is associated with resistance to PI3Ki. Specifically, in BYL719-resistant cells, BYL719 treatment did not induce pS6 and pRB inhibition as detected in BYL719-sensitive cells. By combining PI3Ki with either mammalian target of rapamycin complex 1 (mTORC1) or cyclin D1 kinase (CDK) 4/6 specific inhibitors (RAD001 and abemaciclib, respectively), we were able to overcome the acquired resistance. Furthermore, we found that PI3Ki and CDK 4/6 inhibitors have a synergistic anti-tumor effect when combined in human papillomavirus (HPV)-negative/PIK3CA-WT tumors. These findings provide a rationale for combining PI3Ki and CDK 4/6 inhibitors to enhance anti-tumor efficacy in HNSCC patients.


PLoS ONE ◽  
2014 ◽  
Vol 9 (12) ◽  
pp. e114121 ◽  
Author(s):  
Satoshi Iizuka ◽  
Nobuhiko Oridate ◽  
Masayuki Nashimoto ◽  
Satoshi Fukuda ◽  
Masato Tamura

2014 ◽  
Vol 273 (4) ◽  
pp. 801-809 ◽  
Author(s):  
Federico M. Gioacchini ◽  
Matteo Alicandri-Ciufelli ◽  
Shaniko Kaleci ◽  
Giuseppe Magliulo ◽  
Livio Presutti ◽  
...  

2018 ◽  
Vol 2018 ◽  
pp. 1-9 ◽  
Author(s):  
Hongming Wang ◽  
Weishuang Xue ◽  
Xuejun Jiang

TRIM24 (Tripartite Motif Containing 24) is a recently identified oncogene overexpressed in various cancers. However, the molecular mechanism of TRIM24 in the progression of head and neck squamous cell carcinoma (HNSCC) remains ambiguous. In the present study, we analyzed the expression pattern of TRIM24 in 100 HNSCC tissues and found that TRIM24 was overexpressed in 43/100 HNSCC cases. Significant association was found between TRIM24 overexpression and tumor-node-metastasis (TNM) stage (p=0.0034) and T stage (p=0.0048). Furthermore, we overexpressed and knocked down TRIM24 in Detroit 562 and FaDu cell lines, respectively. TRIM24 overexpression promoted proliferation, colony formation, and invasion, while TRIM24 depletion inhibited proliferation, colony formation, and invasion. Further studies showed that TRIM24 facilitated cell cycle transition and upregulated cyclin D1 and p-Rb. In addition, we found that GLUT3, a key protein involved in regulating glucose metabolism, was altered in HNSCC cells overexpressing TRIM24. We demonstrated that TRIM24 overexpression increased glucose uptake ATP production. Overexpression of TRIM24 increases cell sensitivity to glucose deprivation in Detroit cells. Depleting TRIM24 in FaDu cells demonstrated the opposite results. We also showed that TRIM24 could bind to the promoter region of cyclin D1. In conclusion, TRIM24 is upregulated in HNSCC and promotes HNSCC cell growth and invasion through modulation of cell cycle, glucose metabolism, and GLUT3, making TRIM24 a potential oncoprotein in HNSCC.


Sign in / Sign up

Export Citation Format

Share Document